These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Frontotemporal dementia. Bang J; Spina S; Miller BL Lancet; 2015 Oct; 386(10004):1672-82. PubMed ID: 26595641 [TBL] [Abstract][Full Text] [Related]
29. Review: Clinical, genetic and neuroimaging features of frontotemporal dementia. Convery R; Mead S; Rohrer JD Neuropathol Appl Neurobiol; 2019 Feb; 45(1):6-18. PubMed ID: 30582889 [TBL] [Abstract][Full Text] [Related]
30. Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation. Gazzina S; Archetti S; Alberici A; Bonomi E; Cosseddu M; Di Lorenzo D; Padovani A; Borroni B J Alzheimers Dis; 2017; 57(4):1185-1189. PubMed ID: 28304311 [TBL] [Abstract][Full Text] [Related]
31. Frontotemporal lobar degeneration: diversity of FTLD lesions. Seilhean D; Bielle F; Plu I; Duyckaerts C Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575 [TBL] [Abstract][Full Text] [Related]
32. Clinical aspects of familial forms of frontotemporal dementia associated with parkinsonism. Fujioka S; Wszolek ZK J Mol Neurosci; 2011 Nov; 45(3):359-65. PubMed ID: 21656039 [TBL] [Abstract][Full Text] [Related]
33. [Clinical, pathological, and genetic characteristics of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in the MAPT and PGRN]. Tsuboi Y Brain Nerve; 2009 Nov; 61(11):1285-91. PubMed ID: 19938685 [TBL] [Abstract][Full Text] [Related]
34. Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies. Mackenzie IR; Neumann M J Neurochem; 2016 Aug; 138 Suppl 1():54-70. PubMed ID: 27306735 [TBL] [Abstract][Full Text] [Related]
35. Atypical parkinsonian syndromes: a general neurologist's perspective. Deutschländer AB; Ross OA; Dickson DW; Wszolek ZK Eur J Neurol; 2018 Jan; 25(1):41-58. PubMed ID: 28803444 [TBL] [Abstract][Full Text] [Related]
36. Phenocopy syndrome of behavioral variant frontotemporal dementia: a systematic review. Valente ES; Caramelli P; Gambogi LB; Mariano LI; Guimarães HC; Teixeira AL; de Souza LC Alzheimers Res Ther; 2019 Apr; 11(1):30. PubMed ID: 30935398 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathological Study of Patients With C9ORF72-Associated Frontotemporal Dementia Presenting With Delusions. Shinagawa S; Naasan G; Karydas AM; Coppola G; Pribadi M; Seeley WW; Trojanowski JQ; Miller BL; Grinberg LT J Geriatr Psychiatry Neurol; 2015 Jun; 28(2):99-107. PubMed ID: 25342578 [TBL] [Abstract][Full Text] [Related]
38. What we know about TMEM106B in neurodegeneration. Nicholson AM; Rademakers R Acta Neuropathol; 2016 Nov; 132(5):639-651. PubMed ID: 27543298 [TBL] [Abstract][Full Text] [Related]
39. [Development of disease modifying drugs for dementia-focusing on anti-tau drugs-]. Soeda Y; Takashima A Rinsho Shinkeigaku; 2014; 54(12):1178-80. PubMed ID: 25672738 [TBL] [Abstract][Full Text] [Related]
40. [The molecular pathology of frontotemporal lobar degeneration]. Fujishiro H; Hasegawa M; Arai T Seishin Shinkeigaku Zasshi; 2010; 112(4):313-24. PubMed ID: 20496755 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]